Skip to main content
Biohit Oyj logo

Biohit Oyj — Investor Relations & Filings

Ticker · BIOBV ISIN · FI0009005482 LEI · 74370089ATTSNBXJVT29 HE Manufacturing
Filings indexed 992 across all filing types
Latest filing 2019-04-25 Board/Management Inform…
Country FI Finland
Listing HE BIOBV

Biohit Oyj is a global biotechnology company that develops, manufactures, and markets innovative diagnostic products and services. The company specializes in tools for the early diagnosis and prevention of diseases, with a primary focus on gastroenterology. Its key offerings include the GastroPanel® blood test for assessing stomach health and screening for risks of gastric cancer, as well as diagnostic tests for conditions such as Helicobacter pylori infection. Operating under the mission "Innovating for Health," Biohit's products are designed to support medical research, facilitate early and accurate diagnosis, and improve patient quality of life.

Recent filings

Filing Released Lang Actions
Biohit Oyj:n hallituksen järjestäytyminen
Board/Management Information Classification · 100% confidence The document is a short announcement regarding the internal organization of the Board of Directors of Biohit Oyj, specifically the election of a new Chairman. This falls under the category of board management and structural changes.
2019-04-25 Finnish
Constitutive meeting of Biohit Oyj’s Board of Directors
Board/Management Information Classification · 100% confidence The document announces the outcome of a constitutive meeting of the Board of Directors, specifically the election of a new Chairman. This falls under the category of board management and composition changes. It is not a full report, but a short announcement regarding corporate governance structure.
2019-04-25 English
Biohit Oyj:n varsinaisen yhtiökokouksen päätökset
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement detailing the decisions made at the Biohit Oyj Annual General Meeting (varsinainen yhtiökokous) held on April 24, 2019. It covers the approval of financial statements, dividend decisions, election of board members, and appointment of auditors. Since it reports the specific outcomes and voting results of the meeting, it falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2019-04-24 Finnish
Decisions of the Annual General Meeting of Biohit Oyj
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document reports the specific outcomes and resolutions of an Annual General Meeting (AGM), including the approval of financial statements, dividend decisions, election of board members, and appointment of auditors. While it mentions the availability of minutes, the core content is the declaration of the voting results and decisions made during the meeting, which aligns perfectly with the DVA category.
2019-04-24 English
Publication of Biohit Oyj Annual Report 2018
Annual Report Classification · 100% confidence The document is titled 'Vuosikertomus 2018' (Annual Report 2018) for Biohit Oyj. It contains comprehensive sections including the CEO's review, strategy, history, governance, and detailed financial statements (Tilinpäätös). It is a full-year report covering company activity and financial performance, fitting the definition of an Annual Report (10-K). FY 2018
2019-03-29 Finnish
Publication of Biohit Oyj Annual Report 2018
Annual Report Classification · 100% confidence The document is titled 'Annual report 2018' for Biohit Oyj. It contains comprehensive sections including a review by the President & CEO, strategy, history, corporate governance, and detailed financial statements for the fiscal year 2018. It is a full annual report, not an announcement or a summary. FY 2018
2019-03-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.